The levels of NAIP, BIRC2, XIAP, and BIRC6 were significantly elevated in the subgroups of tumor stages 1-3 compared to their levels in the normal subgroups (Figure 2A), with no discernible differences in their levels in the subgroup of tumor stage 4. The gene discussed is NAIP; the disease is neoplasm.